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Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) displays notorious genetic, antigenic, and clinical variability. Little is
known, however, about the nature and extent of viral variation present within naturally infected animals. By amplifying and cloning the open
reading frame 5 gene from tonsils of naturally infected swine, and by sequencing individual clones, we characterized viral diversity in nine
animals from two farms. All animals harbored multiple PRRSV variants at both the nucleic and the amino acid levels. Structural variation
and rates of synonymous and nonsynonymous nucleotide substitution were no different within known epitopes than elsewhere. Analysis of
molecular variance indicated that differences between farms, among animals within farms, and within individual animals accounted for
92.94, 3.84, and 3.22% of the total viral genetic variability observed, respectively. PRRSV exists during natural infection as a quasispecies
distribution of related genotypes. Positive natural selection for immune evasiveness does not appear to maintain this diversity.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Porcine reproductive and respiratory syndrome virus
(PRRSV) is the causative agent of porcine reproductive and
respiratory syndrome (PRRS), an economically damaging
disease of domestic swine worldwide (Wensvoort et al.,
1991; Benfield et al., 1992). PRRSV was identified as a
member of the family Arteriviridae over a decade ago
(Conzelmann et al., 1993; Meulenberg et al., 1993). Despite
significant subsequent research, the virus has remained dif-
ficult to control. Vaccination, in particular, varies in its
efficacy and often fails to reduce transmission or to alleviate
clinical signs (Dewey et al., 1999; Mavromatis et al., 1999;
Mengeling et al., 1999; Dee et al., 2000; Halbur et al., 2000;
Meng, 2000; Nodelijk et al., 2001). Current control strate-
gies include such costly solutions as testing and removing
positive animals or depopulating and repopulating herds
(Dee and Joo, 1997; Dee et al., 1997, 2001a).
PRRSV infection ranges in severity from subclinical to
lethal and affects swine at both the growth and the repro-
ductive stages (Zimmerman et al., 1997; Mengeling et al.,
2000; Nodelijk, 2002). This remarkable clinical variability
poses a serious barrier to diagnostics, control, and biocon-
tainment. Unfortunately, the root causes of such variability
are poorly understood. It could result from factors operating
at the level of the host, the pathogen, and/or the environ-
ment.
One likely underlying cause for the clinical variability in
PRRS is the biological variability of the virus itself. Euro-
pean varieties of PRRSV differ substantially from North
American varieties genetically and antigenically, implying a
high degree of evolutionary divergence between continents
(Allende et al., 1999; Nelsen et al., 1999; Forsberg et al.,
2001). Within both Europe and North America, PRRSV
exists as a diverse array of genotypes, displaying consider-
able antigenic and clinical heterogeneity but little geograph-
ically relevant population substructure (Dea et al., 1996;
Halbur et al., 1996; Kapur et al., 1996; Mengeling et al.,
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1996; Le Gall et al., 1997; Goldberg et al., 2000; Meng,
2000; Stadejek et al., 2002; Mateu et al., 2003). PRRSV can
vary genetically even within individual herds of pigs (Gold-
berg et al., 2000; Dee et al., 2001b). Laboratory investiga-
tions have shown that PRRSV mutates quickly in pigs
(Rowland et al., 1999; Chang et al., 2002), and that multiple
variants can coexist in experimentally infected animals
(Chang et al., 2002).
PRRSV has a short (approximately 15 kb) single
stranded, positive-sense RNA genome (Benfield et al.,
1992; Conzelmann et al., 1993; Meulenberg et al., 1997).
Small RNA viruses such as PRRSV are thought to exist in
nature as distributions of related genotypes know as “qua-
sispecies” (Eigen and Schuster, 1979; Domingo et al., 1996;
Domingo et al., 2002). The evolutionary plasticity of such
distributions could account for the notorious ability of RNA
viruses to evade host immunity and to evolve novel clinical
manifestations (Domingo et al., 1997). Such effects have
been demonstrated for certain RNA viruses of humans, most
notably human immunodeficiency virus (HIV) (Essajee et
al., 2000; Paolucci et al., 2001; Nowak et al., 2002) and
hepatitis C virus (HCV) (Farci and Purcell, 2000; Farci et
al., 2002; Pawlotsky, 2003). Understanding whether
PRRSV behaves similarly would be critical for designing
rational and realistic strategies to limit its clinical effects.
We hypothesize that PRRSV exists during natural infec-
tion as a quasispecies distribution of related genotypes and
that this variation could account for the inability of tradi-
tional approaches such as vaccination to control PRRS ad-
equately. To test this hypothesis, we sampled naturally
infected animals in the field and characterized viral genetic
variability both within farms and within individual animals
on those farms. We also hypothesize that host immunity
sustains the genetic variability of PRRSV by selecting for
viral variants with novel antigenic properties. To test this
hypothesis, we examined whether gene regions coding for
immunogenic epitopes differed from gene regions not cod-
ing for immunogenic epitopes in their genetic variation and
rates of molecular selection within naturally infected ani-
mals. This article provides the first data on the nature and
extent of within-animal quasispecies-level genomic vari-
ability in PRRSV during natural infection. The results are
pertinent to the control of PRRS in the field, as well as to the
biology and control of positive-sense RNA viruses in gen-
eral.
Results
Blood and tonsil biopsies were collected from 68 pigs on
two farms (Farm A and Farm B). ELISA sample:positive
(S:P) ratios ranged from 0.9 to 2.6 for the 31 pigs from Farm
A, and from 0.2 to 3.3 for the 37 pigs from Farm B, with
seroprevalence rates (S:P ratios  0.4) of 100 and 81%,
respectively. All biopsy samples were histologically con-
firmed to contain tonsillar tissue. PRRSV genomic RNAs
were detected by reverse-transcription PCR in the tonsils of
seven pigs from Farm A (22.6%) and two pigs from Farm B
(5.4%).
The complete open reading frame 5 (ORF5) gene (603
bases) was sequenced directly in all nine PCR-positive
animals (A1–A7, and B1–B2). Comparison of the ORF5
sequences generated from Farms A and B to published
sequences indicated that PRRSV variants recovered from
both farms were highly divergent wild-type North American
viruses and not vaccine revertants. PCR products were also
cloned into plasmid vectors, and individual clones were
sequenced to measure within-animal viral genetic variabil-
ity. Twelve clones from each sample were successfully
sequenced in this manner.
Reverse-transcription, PCR, and DNA sequencing are
error-prone, and associated errors can obscure patterns of
RNA viral variability (Bracho et al., 1998; Malet et al.,
2003). We therefore deemed it necessary to measure the
influence of random errors generated during RT-PCR and/or
sequencing on our results. To estimate this error empiri-
cally, we propagated a field strain of PRRSV in vitro,
purified it to the level of a single clone using a method of
serial limiting dilution, and measured genetic variability
within this sample using protocols identical to those applied
to field samples. Twelve additional sequences were gener-
ated from this limiting dilution (LD) sample, for a total of
78.39 kb of sequence data in this study.
From the data generated, three categories of sequences
were defined. The first category, “modal sequences,” con-
sisted of sequences generated directly from PCR products,
without cloning. These sequences represent the modal se-
quence of the population of molecules within an individual
sample. The second category, “clone sequences,” consisted
of the 12 sequences of individual clones generated for each
sample. The third category, “consensus sequences,” con-
sisted of the consensus of all clone sequences within a
sample, defined for each nucleotide position of ORF5 as that
base represented by the greatest proportion of individual
clone sequences.
No two modal sequences in the study were identical at
the nucleic acid level. At the amino acid sequence level, the
modal sequences from Farm A represented four distinct
amino acid sequences, and both modal sequences from
Farm B were different. The mean pairwise difference
among modal sequences from Farm A was 2.85/603 nucle-
otide positions and 1.43/201 amino acid positions, and the
pairwise difference between the two modal sequences from
Farm B was 5/603 of nucleotide positions and 4/201 amino
acid positions. The mean pairwise difference among all nine
modal sequences from both farms was 27.17/603 nucleotide
positions and 9.94/201 amino acid positions, which is com-
parable to the mean pairwise difference among a larger set
of 55 previously published sequences from Illinois and
surrounding states (39.26/603 nucleotide positions and
15.72/201 amino acid positions; Goldberg et al., 2000),
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indicating that the viral diversity sampled in this study is
geographically representative.
Examination of clone sequences revealed that all animals
in the study harbored multiple variants of PRRSV at both
the nucleic acid and the amino acid levels. Descriptive
statistics on the genetic variation of clone sequences within
individual animals are given in Table 1. Clone sequences
differed by an average of 2.13/603 nucleotide positions and
1.44/201 amino acid positions within individual animals.
The most divergent variants recovered from any animal
differed by eight nucleic acid positions and four amino acid
positions. Diversity within the LD sample was lower by all
measures than that within any field sample.
In most cases, the consensus sequence for a sample was
identical to the modal sequence for that same sample (Table
1). Where this was not the case, the consensus sequence
differed from the modal sequence by only a single position
(nucleotide or amino acid). The overall congruity of the
modal and consensus sequences indicates that sequencing
12 clones per sample provided an adequate representation of
overall genetic variability within each sample. Most clone
sequences differed by at least one position (nucleotide or
amino acid) from the consensus sequence, indicating that
the consensus sequence was (paradoxically) not highly repre-
sented among individual PRRSV genomes within an animal.
The 108 clone sequences generated from field samples
represented a total of 73 haplotypes (unique sequences) at
the nucleic acid level and 54 haplotypes at the amino acid
level. Fig. 1 depicts relatedness among the haplotypes at the
nucleic acid level as a phylogenetic tree. The tree was
constructed using the neighbor joining algorithm of Saitou
and Nei (1987), implemented with the computer program
PAUP* (Swofford, 2000). Pairwise distances between se-
quences were corrected for multiple substitutions using a
maximum likelihood distance correction in which the tran-
sition/transversion ratio was set to 11.72, the nucleotide
frequencies (A, C, G, and T, respectively) were set to 0.193,
0.260, 0.267, and 0.278, and in which the distribution of
rates at variable sites was described using a -distribution
with shape parameter   1.380, with no sites assumed
invariant. These parameter values were estimated from the
data using an iterative likelihood ratio approach imple-
mented using the computer program Modeltest, Version
3.06 (Posada and Crandall, 1998).
Table 1
Descriptive statistics on quasispecies variation in PRRS virus
IDa nb hc conmod?d clonecone clonemodf Positionsg sh di Range dj
Nucleic acids
A1 12 8 Yes 7 7 603 9 1.50 0–4
A2 12 10 Yes 8 8 603 14 2.61 0–7
A3 12 11 Yes 10 10 603 13 2.44 0–4
A4 12 6 Yes 6 6 603 7 1.30 0–4
A5 12 7 No (1) 6 11 603 6 1.24 0–3
A6 12 9 Yes 8 8 603 8 1.65 0–3
A7 12 9 Yes 9 9 603 16 3.03 0–8
B1 12 9 Yes 8 8 603 17 2.97 0–8
B2 12 9 Yes 8 8 603 14 2.47 0–5
LD 12 4 Yes 3 3 603 6 1.00 0–4
Amino acids
A1 12 5 Yes 5 5 201 6 1.00 0–3
A2 12 8 No (1) 7 12 201 10 1.80 0–4
A3 12 7 No (1) 7 12 201 6 1.14 0–2
A4 12 5 Yes 5 5 201 5 0.97 0–3
A5 12 5 No (1) 5 10 201 4 0.91 0–3
A6 12 8 Yes 7 7 201 7 1.48 0–3
A7 12 8 Yes 9 9 201 11 2.20 0–5
B1 12 7 Yes 7 7 201 12 2.00 0–5
B2 12 8 Yes 6 6 201 8 1.47 0–4
LD 12 3 Yes 2 2 201 2 0.33 0–2
a ID  sample identifier.
b n  number of sequences.
c h  number of haplotypes (unique clone sequences).
d Conmod?  is the consensus sequence identical to the modal sequence? (If no, then number of differing positions).
e Clonecon  number of clone haplotypes that are different from the consensus sequence.
f Clonemod  number of clone haplotypes that are different from the modal sequence.
g Positions  number of positions (nucleotide or amino acids) per sequence.
h s  number of segregating sites (variable positions).
i d  mean pairwise differences between all clone sequences within a sample (units  nucleic or amino acid positions).
j Range d  range of pairwise differences between all clone sequences within a sample (units  nucleic or amino acids positions).
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The phylogenetic tree in Fig. 1 demonstrates that PRRSV
variants from Farm A are genetically distinct from those of
Farm B. PRRSV variants from both farms are genetically
distinct from either the VR-2332 vaccine variant or the LD
variant. Within Farm B, clone sequences from animal B1
form a monophyletic group, distinct from clone sequences
from animal B2. Within Farm A, clone sequences from
animals A2 and A4 form a monophyletic group, but clone
sequences from all other animals are paraphyletic.
Individual animals harbored an average of 8.7 nucleic
acid haplotypes and 6.8 amino acid haplotypes per 12 clone
sequences (see Table 1). The number of nucleic acid hap-
lotypes (4) and amino acid haplotypes (3) in the LD sample
was lower than that in any field sample. The structure of
within-sample genetic diversity is depicted graphically in
Fig. 2 as a set of “mismatch distributions,” or histograms of
pairwise genetic differences (“mismatches”) among se-
quences within a sample (Rogers and Harpending, 1992).
The nine field samples differ considerably in the nature and
extent of genetic variation present, at both the amino acid
and nucleic acid levels. The structure of genetic variation
within the LD sample clearly differs from that of any field
sample, with most pairs of sequences differing by zero or
one mismatches.
Fig. 3 shows the distribution of structural (amino acid
level) variation along the ORF5 gene within individual
samples. Although field samples differ considerably in the
positions at which their clone sequences vary, no universal
hypervariable regions are apparent. Structural variation
among clone sequences within the LD sample is restricted
to two amino acid positions and is clearly lower than that
within any field sample.
Previous studies have mapped the ORF5 gene product
antigenically and have identified three linear epitopes (Ro-
driguez et al., 2001; Ostrowski et al., 2002; Plagemann et
al., 2002). These are located at amino acid positions 27–30
(nonneutralizing), 37–45 (neutralizing), and 170–201 (non-
neutralizing) and are depicted as thickened lines along the
horizontal axis of Fig. 3. Table 2 presents data on quasi-
Fig. 1. Phylogenetic tree of PRRSV ORF5 sequences. The viral ORF5 gene
was amplified and cloned, and individual clones were sequenced (12 clones
per sample) directly from tonsil biopsies of infected swine on two farms.
Taxon names refer to the farm (A or B), animal (1–7), and clone (a–l). LD
refers to sequences generated from the limiting dilution experiment (see
text for full explanation). VR-2332, the U.S. reference strain (GenBank
Accession No. U87392) is also included for comparison. The tree is rooted
using the European reference strain (Lelystad; GenBank Accession No.
M96262). Numbers below branches are bootstrap values (%) obtained from
1000 bootstrap replicates of the data. Only bootstrap values 50% are
shown.
Fig. 2. Mismatch distributions of PRRSV ORF5 sequences. The ORF5
gene was amplified and cloned, and individual clones were sequenced (12
clones per sample) directly from tonsil biopsies of infected swine on two
farms (A and B). Individual graphs are histograms of pairwise genetic
differences (mismatches, measured as the raw number of different posi-
tions) among pairs of sequences within an animal (A1–B2) or sample (LD,
the limiting dilution sample). Open bars represent nucleic acid mismatches,
and shaded bars represent amino acid mismatches.
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species-level genetic variation within samples separately for
epitopic regions and nonepitopic regions, as well as for the
ORF5 gene as a whole. All three epitopic regions were
combined in this analysis because results from the individ-
ual regions did not differ.
Genetic diversity within field samples (measured as nu-
cleotide diversity; Nei, 1987) did not differ significantly
between epitopic and nonepitopic regions (paired Student’s
t test; t  0.56; P  0.59; 8 d.f.). The strength of natural
selection on different gene regions was measured as the
ratio of synonymous substitutions per synonymous site
to non synonymous substitutions per nonsynonymous site
(ds/dn), averaged across all pairs of haplotypes within a
sample (Nei and Gojobori, 1986). In four cases, this ratio
was undefined in the epitopic regions because no nonsyn-
onymous substitutions were observed (Table 2). Consider-
ing only the remaining five cases, no significant difference
existed in ds/dn between the epitopic and nonepitopic re-
gions (paired Student’s t test; t  1.03; P  0.36; 4 d.f.). In
both epitopic and nonepitopic regions, however, the average
value of ds/dn was greater than 1, indicating a predominance
of synonymous substitutions and an overall pattern of sta-
bilizing selection within ORF5.
Table 3 presents the results of an analysis of molecular
variance (AMOVA) (Excoffier et al., 1992) conducted on
clone sequences from the field samples in this study using
the computer program Arlequin (Schneder et al., 2000).
AMOVA partitions genetic variation into hierarchical com-
ponents and thus quantifies population genetic substructure.
The majority of the total genetic variation present among
clone sequences in this study (92.94%) is accounted for by
differences between Farm A and Farm B. A smaller, but
nevertheless statistically significant, proportion of the total
genetic variation (3.84%) is accounted for by differences
among animals within farms. Genetic diversity among clone
sequences within individual animals accounts 3.22% of the
total genetic variation observed and is also statistically sig-
nificant.
Discussion
The results of this study demonstrate that multiple vari-
ants of PRRSV can exist simultaneously on farms, and
within individual animals, during natural infection. Variants
Fig. 3. Quasispecies-level structural variation of PRRSV within naturally
infected animals. The ORF5 gene was amplified and cloned, and individual
clones were sequenced (12 clones per sample) directly from tonsil biopsies
of infected swine on two farms (A and B). The locations of variable amino
acids along the ORF5 gene are represented for each animal (A1–B2) or
sample (LD, the limiting dilution sample) as vertical bars. Bars are pro-
portional in height to the number of sequences (of 12 in all cases) differing
from the consensus sequence at that position. Heights of bars range from
1 to 5 amino acid differences. Thick lines along the horizontal axis indicate
the positions along ORF5 of known linear epitopes.
Table 2
Quasispecies variation and selection in epitopic and nonepitopic regions of the PRRSv ORF 5 gene
IDb nc Epitopic regionsa Nonepitopic regionsa Whole genea
hd pose f sg ds/d nh hd pose f sg ds/d nh hd pose f sg ds/d nh
A1 12 2 135 1.23 1 0.00 8 468 2.85 8 3.43 8 603 2.49 9 3.05
A2 12 4 135 4.94 4 1.98 7 468 4.14 10 2.58 9 603 4.32 14 3.45
A3 12 3 135 3.48 2 N/A 10 468 4.21 11 4.29 11 603 4.05 13 4.69
A4 12 3 135 3.70 3 2.23 5 468 1.72 4 3.43 6 603 2.16 7 2.27
A5 12 1 135 0.00 0 N/A 7 468 2.65 6 3.24 7 603 2.06 6 3.13
A6 12 1 135 0.00 0 N/A 9 468 3.53 8 2.69 10 603 2.74 8 2.41
A7 12 2 135 1.23 1 N/A 9 468 6.12 15 3.63 9 603 5.03 16 2.59
B1 12 5 135 8.64 7 3.27 7 468 3.85 10 2.10 9 603 4.92 17 2.48
B2 12 4 135 4.71 3 3.13 8 468 3.92 11 3.03 9 603 4.10 14 4.07
LD 12 2 135 1.23 1 0.00 4 468 1.78 5 6.86 4 603 1.66 6 5.95
a Epitopic regions include nucleotide positions 79–90, 109–135, and 508–603. All other positions were considered nonepitopic.
b ID  sample identifier (LD  limiting dilution sample).
c n  number of sequences.
d h  number of haplotypes (unique sequences).
e pos  number of nucleotide positions.
f   nucleotide diversity, or mean proportion of pairwise nucleotide sequence differences (multiplied by 1000).
g s  number of segregating sites (variable positions).
h ds/dn  ratio of the proportion of synonymous substitutions per synonymous site to nonsynonymous substitutions per nonsynonymous site, averaged over
all pairs of haplotypes within a sample. N/A refers to cases where dn  0, making ds/dn undefined.
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of PRRSV existed at both the genetic (nucleic acid) and
structural (amino acid) levels. Variation among modal se-
quences (directly sequenced PCR amplicons) from different
animals on a farm was considerable, with no two animals on
any farm sharing an identical modal ORF5 nucleic acid
sequence. Variation within animals was also considerable;
few clone sequences within any animal were identical. In-
dividual animals varied widely in the diversity of clone
sequences that they harbored.
The extent of variation observed within animals in this
study cannot be explained by random errors generated during
PCR or sequencing. Diversity in the LD sample was lower by
all measures than was diversity in the nine field samples.
Variability in the LD sample reflects the combined error asso-
ciated with (1) replication of the virus from a single infectious
unit in a single tissue culture well, (2) reverse transcription, (3)
nested PCR, and (4) DNA sequencing. The limiting dilution
experiment therefore yields an “upper end” estimate of the
variability that could be attributed to random error in this study.
The greater level of viral genetic diversity observed in all field
samples must therefore reflect the presence of multiple viral
variants within the tonsillar tissue of the animals at the time of
sampling.
The nature of the viral genetic variation observed within
individual animals in this study justifies the use of the
descriptor quasispecies. A hallmark feature of quasispecies
variation is that few, if any, individual sequences within a
“mutant swarm” exactly match the average, or consensus,
sequence (Domingo et al., 1996; Domingo, 2002). As Table
1 demonstrates, few clone sequences exactly matched their
respective consensus or modal sequence. Wild-type PRRSV
in naturally infected swine therefore exists as a quasispecies
distribution of related but distinct viral variants.
We believe that quasispecies variation in PRRSV is a
general phenomenon, and that its presence should be ex-
pected wherever PRRSV occurs. All nine animals examined
in this study were found to harbor genetic and structural
variants of PRRSV. This occurred even though the two
farms sampled in this study had highly divergent North
American variants of PRRSV. Quasispecies variation in
PRRSV therefore appears to occur independently of viral
genotype or host population.
Less clear than the existence of quasispecies variation in
PRRSV is its underlying cause. Quasispecies variation
within individual animals could result either from viral
mutations occurring within the animal itself or from trans-
missions of exogenous viral variants from other animals.
The phylogenetic tree shown in Fig. 1 bears on this issue.
Complete monophyly of clone sequences from individual
animals would be expected in the absence of between-
animal transmission. However, clone sequences from only
three of nine animals form monophyletic groups on this tree.
Other clades on the tree consist of intermingled sequences
from two or more animals. Many animals share identical
haplotypes. We interpret this pattern as evidence that be-
tween-animal transmission of PRRSV does occur and that it
does contribute to the quasispecies variation observed
within animals. Nevertheless, many separate clone se-
quences from the same animal appear closely related, and
distinct from clone sequences from other animals. We in-
terpret this pattern as evidence that within-animal mutation
also occurs and that it too contributes to the quasispecies
variation observed within animals. In other words, our phy-
logenetic analysis provides evidence that both phenom-
ena—within-animal mutation and between-animal transmis-
sion—contribute to the generation and maintenance of
quasispecies diversity within individual animals.
Individual animals were not uniform in the number or
diversity of distinct viral variants that they harbored. Differ-
ences among animals in these measures could reflect differ-
ences in the duration of infection or the number of horizontally
transmitted exogenous viral variants to which they were ex-
posed. If so, then quasispecies diversity within animals may be
epidemiologically informative. Measures of viral diversity
within animals could be used to reconstruct the timing of
infection or the frequency of horizontal viral transmission.
In this study, for example, modal sequences from Farm B
were approximately twice as diverse genetically as modal
sequences from Farm A. Phylogenetically, clone sequences
from Farm B animals tended to cluster into monophyletic
groups to a greater degree than did clone sequences from
Farm A animals. These results would be consistent with a
higher frequency of between-animal viral transmission on
Farm A than on Farm B, and/or a longer duration of infec-
tion for animals from Farm B. This interpretation is consis-
tent with the clinical history of animals from the two farms.
All animals sampled from Farm A were housed in a single,
large building, whereas animals sampled from Farm B were
housed in several smaller buildings. The potential for hor-
izontal viral transmission was therefore greater for animals
Table 3
Analysis of molecular variance (AMOVA) of quasispecies diversity for PRRSv ORF5 sequences from two farms
Variance component Observed partition Pa -statistics
d.f. Sum of squares Variance % total variance
Among farms a2 1 1167.27 30.83 92.94 0.025 CT  0.544
Among animals within farms b2 7 114.61 1.28 3.84 0.001 SC  0.968
Within animals c2 99 105.67 1.07 3.22 0.001 ST  0.929
a Probability of obtaining a more extreme variance component and -statistic than the observed values by chance alone, calculated by 1000 random
permutations of the data according to the method of Excoffier et al. (1992), implemented using the computer program ARLEQUIN (Schneder et al., 2000).
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from Farm A than for animals from Farm B. Also, animals
from Farm A had entered the farm between 4 and 8 weeks
prior to sampling, whereas animals on Farm B had been
born on the farm between 7 and 11 weeks prior to sampling.
Durations of infection were therefore potentially longer for
animals from Farm B than for animals from Farm A.
We do not find evidence of any effect of positive natural
selection for immune evasiveness in maintaining quasispe-
cies variation within the animals sampled. Structural varia-
tion in ORF5 appeared to be randomly distributed across the
length of the gene (Fig. 3). Variation was not concentrated
in any of the known linear epitopes of ORF5. Relative rates
of synonymous and nonsynonymous nucleic acid substitu-
tion did not differ between epitopic and nonepitopic regions
of ORF5. In the animals sampled, therefore, immune selec-
tion pressure does not appear to drive the diversification of
PRRSV by selecting for variants that can evade neutraliza-
tion. On the contrary, the fact that ds/dn ratios were uni-
formly greater than 1 suggests that the overall pattern of
evolution of the PRRSV quasispecies within animals is
dominated by stabilizing selection (Nei, 1987). We con-
clude that, in the animals sampled in this study, quasispecies
diversity is generated by random viral mutation and is
limited by stabilizing selection.
We cannot rule out the possibility that the evolution of
other immunogenic regions of ORF5 may be driven by
positive selection. Epitopes important for cell-mediated im-
munity may, for example, behave in such a fashion. Fur-
thermore, we did not consider in this study the immune
status of the particular animals sampled. Future studies
quantifying the relationship between host immunity and
quasispecies variation in PRRSV are clearly warranted.
The results of this study and their associated interpreta-
tions are limited to the ORF5 gene. We chose to examine
this gene because of its high variability and known immu-
nogenicity. Other loci within the PRRSV genome would
almost certainly display different (probably lower) levels of
quasispecies variability (Chang et al., 2002). The molecular
evolution of other loci could also be driven by positive
selection in ways that ORF5 does not appear to be. Studies
examining the nature and extent of quasispecies variation in
genes coding for the other structural proteins of PRRSV are
also warranted.
A further limitation of this study is that our techniques
did not allow us to determine which viral clone sequences
represented infectious viral particles, and which did not. We
chose to amplify viral RNA directly from tissue to maxi-
mize viral detection (Wills et al., 2003) and to avoid biases
associated with virus isolation. Virus isolation could, in and
of itself, select for a nonrepresentative subset of viral vari-
ants (those adaptable to growth in tissue culture), thus lead-
ing to systematic underestimations of quasispecies diver-
sity. Nevertheless, none of the 120 clone sequences
generated in this study were found to contain premature stop
codons, despite significant numbers of nonsynonymous sub-
stitutions throughout. This observation, and the fact that
PRRSV can freely recombine, makes it likely that the se-
quences we have examined are relevant to the replication
and transmission of the virus.
Our analysis of molecular variance demonstrated that
differences among clone sequences within animals ac-
counted for only 3.22% of the total genetic variation ob-
served. This level of variation was nevertheless comparable
to that observed among animals within farms (3.84%). This
finding was surprising, because it implies that an adequate
estimate of the genetic variability of PRRSV on a farm
could, in theory, be made by sampling viral variants within
a single animal from that farm. This may hold true, how-
ever, only for populations in which animals can freely
exchange viral variants through horizontal transmission.
The amount of genetic variation within individual ani-
mals in this study was, in an absolute sense, small. This
amount of variation was statistically significant, however,
and we argue that it is also biologically significant. The
variation observed in PRRSV at all geographic levels (from
interanimal to intercontinental) must originate from small
mutations occurring within individual animals. In an ulti-
mate sense, therefore, the quasispecies variation observed
within individual animals in this study is of greater biolog-
ical significance for understanding the genesis of variability
in PRRS than is variation at any other level.
In other RNA viral systems, the nature and extent of
quasispecies variation is a reliable indicator of the course of
clinical disease (Essajee et al., 2000; Farci and Purcell,
2000; Farci et al., 2000; Paolucci et al., 2001). Studies
examining the relationship between quasispecies variation
in PRRSV and the course of clinical disease would be
particularly interesting. So too would be studies elucidating
the factors that determine how and why animals differ in the
diversity of PRRSV variants that they harbor, particularly as
such differences pertain to the duration of infection and the
epidemiology of horizontal transmission on farms.
Finally, this study has implications for the control of
PRRS in the field. If, as we have demonstrated, every
animal on a farm harbors genetically and structurally diver-
gent viral variants, then every animal must be considered a
risk for the emergence of viruses with novel clinical and/or
antigenic properties. Limiting contact of infectious animals
within and between herds should, in this light, be considered
of paramount importance to the control and biocontainment
of PRRS. Any effective strategy for managing PRRSV (or
other similar RNA viruses) must embrace the inherent vari-
ation of the pathogen, understand its root causes and con-
sequences, and offer rational solutions accordingly.
Materials and methods
Field sampling
Clinical samples were collected in 2002 from swine on
two farms in Illinois with histories of long-term (over 3
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years), chronic reproductive losses attributable to PRRS.
Farm A was a 2400-sow, single-site, breed-to-wean facility.
Farm B was an 800-sow, single-site, farrow-to-finish facil-
ity. Biosecurity measures were in place on both farms to
guard against the introduction of PRRSV from exogenous
sources.
A cross-section of growing female replacement breeding
swine was sampled on each farm (31 individuals on Farm A
and 37 individuals on Farm B). Swine were between 4 and
30 weeks of age and weighed between approximately 10
and 150 kg. Swine on Farm A had been introduced into a
single large building between 4 and 8 weeks prior to sam-
pling from a PRRS-negative source herd. Swine on Farm B
had been born on the farm and were sampled between 7 and
11 weeks of age. Swine were sampled evenly with respect
to size and age and randomly with respect to their physical
locations within buildings and pens.
Two clinical samples were collected from each individ-
ual animal: blood and a tonsil biopsy. Animals were re-
strained for sample collection in pens using hand-held cable
snares. Blood was collected into sterile 5-ml vacuum blood
collection tubes using standard venipuncture techniques
with a 20-G, 1.5-in needle. Tonsil biopsies were collected
using a novel method involving local analgesia and individ-
ually sterilized punch biopsy instruments. This technique
was chosen because of the predilection for PRRSV to per-
sist in tonsillar tissue (Beyer et al., 2000; Christopher-
Hennings et al., 2001; Horter et al., 2002; Wills et al., 2003)
and is fully described elsewhere (Lowe et al., 2003).
Serum was separated from blood via centrifugation and
submitted for PRRSV testing using a commercial ELISA kit
(HerdCheck Elisa Kit, Idexx, Inc.) at the University of
Illinois Veterinary Diagnostic Laboratory. Tonsil biopsies
were placed in RNAlater stabilizing buffer (Ambion, Inc.)
in the field. Sections of tonsil tissue were subsequently fixed
in 10% neutral buffered formalin for histologic confirma-
tion.
In vitro methods
A previously characterized field isolate of PRRSV (Gen-
Bank Accession No. AF176446; Goldberg et al., 2000) was
chosen for an empirical estimation of the contribution of
reverse-transcription PCR and sequencing related error to
the measurement of quasispecies variability in this study.
Tenfold serial dilutions of this viral isolate were inoculated
onto 12-well rows of 96-well tissue culture plates contain-
ing confluent monolayers of MARC-145 cells in Eagle’s
minimum essential medium with Earl’s salts, 10% fetal
bovine serum, 100 units/ml penicillin, 100 g/ml strepto-
mycin, 0.25 g/ml amphotericin B, and 50 g/ml gentamy-
cin sulfate, and incubated at 37°C in the presence of 5%
CO2 for 5 days or until maximum cytopathic effect was
observed. When a single positive well was observed in the
row containing the highest dilution, the supernatant from
this well was harvested, diluted serially again, and inocu-
lated onto another 96-well plate as described above. This
process was repeated three times in succession, to ensure
that the final supernatant contained viral particles derived
from only a single infectious unit. Genetic variability was
measured in this limiting dilution sample as described be-
low for clinical samples. This measure provided an “upper-
end estimate” of error in this study, in that it reflected the
combined errors associated with growth of the isolate in
tissue culture, reverse transcription, nested PCR, and DNA
sequencing.
RNA isolation and RT-PCR
Tonsil biopsy sections were homogenized using a rotor-
stator homogenizer, and total RNA was extracted from
homogenates using a commercial kit (RNeasy Kit, Qiagen,
Inc). RNA was extracted from cell-culture supernatants
using a commercial kit (Viral RNA Mini Kit, Qiagen, Inc.).
The viral gene chosen for study was ORF5. The ORF5
gene has been well characterized among field isolates and
has become the “industry standard” for measuring genetic
variability in PRRSV. ORF5 varies within and between
farms and mutates rapidly during serial passage in pigs
(Kapur et al., 1996; Rowland et al., 1999; Goldberg et al.,
2000; Dee et al., 2001b; Chang et al., 2002). The ORF5
gene product is highly antigenic, and highly antigenically
variable among field isolates (Dea et al., 1996, 2000; Pir-
zadeh and Dea, 1998; Pirzadeh et al., 1998; Yoon et al.,
1997). The ORF5 protein contains known, mapped neutral-
izing and nonneutralizing epitopes (Pirzadeh and Dea,
1997; Weiland et al., 1999; Yang et al., 2000; Rodriguez et
al., 2001; Ostrowski et al., 2002).
ORF5 was amplified from extracted RNA using a novel
“heminested” RT-PCR, incorporating an internal forward
primer that overlaps partially with the external forward
primer (the two reverse primers do not overlap). Primers
4FEd (5-ATGTGCGRYTGCTYCATTTCATGACACC-3),
4FId (5-TCATGACACCTGARRCCATGAGGTGGGC-3),
6REd (5-AGGTGCARAAGCCCYAGCAGTCGGCCGC-3),
and 6RId (5-GCCAADAKCACCTTTTSTGGAGSCGTGC-3)
were designed to anneal to conserved genomic regions in
ORFs 4 and 6 and to amplify a 746-bp region containing the
complete North American ORF5 gene sequence. Incorpo-
ration of degenerate bases maximized the ability of the PCR
to amplify genetically divergent PRRSV variants. The ex-
ternal primer set (4FEd and 6REd) successfully amplifies
ORF5 in both the European and the North American vari-
eties of PRRSV, and the internal primer set (4FId and 6RId)
is selective for North American PRRSV, but amplifies even
the most genetically divergent isolates within the North
American subtype. Preliminary data (not shown) indicate
that this PCR is as sensitive as commercially available
diagnostic PCRs for PRRSV. Nevertheless, we acknowl-
edge that limitations to the sensitivity of this PCR exist.
Reliance on this PCR for identification of positive animals
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in this study may have led to underrepresentations of ani-
mals with low viral loads and/or long durations of infection.
RT-PCR was performed in a “one-tube system” (RobusT
I RT-PCR Kit; Finnzymes, OY), which incorporates a
proofreading DNA polymerase to reduce PCR-associated
error (Malet et al., 2003). Reactions contained 1 RobusT
Reaction Buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 0.8 g/l
bovine serum albumin, 2.5 units AMV reverse transcriptase,
0.5 units DyNAzyme EXT DNA polymerase, 20 units
RNAse Out RNA inhibitor (Invitrogen, Inc.), 5 pmol of
primers 4FEd and 6REd, and 10–20 ng of template RNA in
a 25 l volume. Reaction conditions consisted of an initial
reverse transcription step at 42°C for 30 min, then an initial
denaturation step at 94°C for 2 min, followed by 35 cycles
of denaturation (94°C for 30 s, annealing (65°C for 30 s, and
extension (72°C for 1 min), and a final extension step at
72°C for 4 min. Second-round PCRs contained 50 mM
Tris–HCl (pH 9.0), 15 mM (NH4)2SO4, 1.5 mM MgCl2,
0.1% Triton X-100, 0.2 mM dNTPs, 0.8 g/l bovine
serum albumin, 0.5 units DyNAzyme EXT DNA polymer-
ase, 5 pmol of primers 4FId and 6RId, and 5 l of the
first-round reaction in a 25 l volume. Reaction conditions
consisted of an initial denaturation step at 94°C for 2 min,
followed by 35 cycles of denaturation (94°C for 30 s,
annealing (65°C for 30 s), and extension (72°C for 1 min),
and a final extension step at 72°C for 4 min. Appropriate
negative control reactions were performed at all stages to
detect potential cross-contamination.
PCR products were visualized by gel electrophoresis in
1% agarose stained with ethidium bromide under ultraviolet
illumination. Amplicons were excised from gels using ster-
ile razor blades and were purified from the agarose matrix
using a commercial kit (Zymoclean Gel DNA Recovery Kit,
Zymo Research, Inc.).
Cloning and plasmid purification
To measure within-animal genetic variation in PRRSV,
PCR amplicons were cloned into plasmid vectors and indi-
vidual inserts were sequenced. Because PCR products were
blunt-ended (a proofreading DNA polymerase was used to
minimize PCR errors; Malet et al., 2003), amplicons were
first subjected to an “A-tailing” procedure in which adenine
overhangs were added to blunt 5 ends to facilitate TA
cloning. A-tailing was performed in a 10 l reaction volume
containing 20 mM Tris–HCl (pH 8.4), 50 mM KCl, 1.5 mM
MgCl2, 0.2 mM dATP, 5 units Taq DNA polymerase, and 5
l of gel-purified PCR amplicon, incubated at 70°C for 25
min. A-tailed PCR products were cloned into plasmid vec-
tors for subsequent transformation of electroporated DH5
Escherichia coli cells, using a commercial kit (pGEM-T
Easy Vector System, Promega, Inc.), plated onto LB agar
plates containing ampicillin, IPTG, and X-Gal, and incu-
bated at 37°C for 16–24 h. Controls were performed at all
stages of cloning and transformation to ensure the efficiency
of transformation and to detect potential cross-contamina-
tion.
Twelve bacterial transformant colonies were randomly
selected from each sample for plasmid purification and
sequencing. Selected colonies were grown in LB broth for
8 h and were subjected to plasmid isolation and purification
using a high-throughput commercial kit (QIAprep 96 Turbo
Kit, Qiagen, Inc.).
Sequence determination and analyses
All PCR products were directly sequenced on ABI 377
automated fluorescent DNA sequencers (Applied Biosys-
tems, Inc.), located at the University of Illinois W.M. Keck
Center for Comparative and Functional Genomics, with
primers 4FId and 6RId. Amplicons were sequenced in both
directions until all ambiguous bases were resolved. Purified
plasmids from all clones were sequenced at the same facil-
ity, using standard M13 forward and reverse sequencing
primers. Plasmid inserts were also sequenced in both direc-
tions until all ambiguous bases were resolved.
All sequences were hand-edited and aligned with respect
to reference sequences using the computer program Clustal
X (Jeanmougin et al., 1998). All alignments were checked
manually. Phylogenetic analyses were performed using the
computer programs PAUP*, version 4 (Swofford, 2000),
MacClade, version 4.0 (Maddison and Maddison, 2000),
and Modeltest, version 3.06 (Posada and Crandall, 1998).
Population genetic analyses were performed using the pro-
grams MEGA2, version 3.0 (Kumar et al., 2000), Arlequin,
version 2.000 (Schneder et al., 2000), and Mismatch, ver-
sion 2b (Rogers, 1995). Tests of molecular selection (syn-
onymous and nonsynonymous substitution rate tests) were
conducted according to the method of Nei and Gojobori
(1986), using the computer program SNAP (hiv-web.lanl.
gov; Korber, 2000). Statistical analyses were performed
using the computer program SAS, version 8.2 (SAS Insti-
tute, Inc.). Associations were considered statistically signif-
icant at the   0.05 level.
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